Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis
Open accessThe DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index; 36 of the 74 sources its claims cite were checked for support.
Abstract
Despite its abundance in the environment, iron is poorly bioavailable and subject to strict conservation and internal recycling by most organisms. In vertebrates, the stability of iron concentration in plasma and extracellular fluid, and the total body iron content are maintained by the interaction of the iron-regulatory peptide hormone hepcidin with its receptor and cellular iron exporter ferroportin (SLC40a1). Ferroportin exports iron from duodenal enterocytes that absorb dietary iron, from iron-recycling macrophages in the spleen and the liver, and from iron-storing hepatocytes. Hepcidin blocks iron export through ferroportin, causing hypoferremia. During iron deficiency or after hemorrhage, hepcidin decreases to allow iron delivery to plasma through ferroportin, thus promoting compensatory erythropoiesis. As a host defense mediator, hepcidin increases in response to infection and inflammation, blocking iron delivery through ferroportin to blood plasma, thus limiting iron availability to invading microbes. Genetic diseases that decrease hepcidin synthesis or disrupt hepcidin binding to ferroportin cause the iron overload disorder hereditary hemochromatosis. The opposite phenotype, iron restriction or iron deficiency, can result from genetic or inflammatory overproduction of hepcidin.
Overview
CoChat Summary
TL;DR
The review describes how hepcidin binding to ferroportin controls systemic iron homeostasis by blocking cellular iron export, thereby regulating plasma iron, erythropoiesis, and host defense. Dysregulation of this axis causes iron overload such as hereditary hemochromatosis or iron-restrictive anemias, making it a therapeutic target.
Key findings
- Hepcidin, a 25-amino-acid peptide (MW 2.8 kD) present at approximately 2–20 nM in healthy humans, binds ferroportin (SLC40A1; 571 amino acids, ~65–70 kD) and inhibits iron export by occluding the open-outward conformation and inducing endocytosis/degradation.
- Ferroportin exports iron from duodenal enterocytes, iron-recycling macrophages, and hepatocytes; adult humans have total body iron of approximately 3–4 g with daily losses of only 1–2 mg, while plasma transferrin holds only 2–3 mg of iron but delivers 20–25 mg/day.
- The erythron contains approximately 2–3 g of iron, about 2/3–3/4 of total body iron; hepatocyte stores contain up to 1 g, the spleen normally about 0.05 g, and other tissues about 0.3 g.
- Loss of hepcidin or disrupted hepcidin binding to ferroportin causes hereditary hemochromatosis; excessive hepcidin, such as from TMPRSS6 mutations, causes iron-refractory iron deficiency anemia (IRIDA), and inflammatory hepcidin increases produce hypoferremia and nutritional immunity.
Methods
- Narrative review synthesizing published literature; no primary experimental design, sample, or statistical analysis is reported.
- The text integrates structural, genetic, physiological, and clinical evidence from cited studies, including mouse models and human disease examples.
- Not stated in the paper: systematic search strategy, inclusion/exclusion criteria, or data-extraction methods.
Limitations
- The paper states unresolved issues: how ferroportin’s two divalent metal-binding sites mediate export is not clear; the energetics of iron export are not well characterized; functional consequences of tissue-specific ferroportin glycosylation are not understood; the quantitative contribution of hepcidin clearance mechanisms is unknown; and the physiological role of microRNA regulation is uncertain.
- Evident from the text: as a narrative review, it lacks a described systematic search or formal quality assessment, so conclusions depend on selected cited literature.
- Not stated in the paper: an explicit limitations section or discussion of publication bias.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 A current model of hepcidin (orange) interaction with ferroportin (blue) in which binding is dependent on iron (green). The framework of helices that make up ferroportin are depicted as cylinders connected by extracellular and intracellular disordered loops. The side chains that make up the binding sites for iron are shown. Modified from [14].](https://figures.cochat.ai/paper-figures/a8d0b48e97e349ad9b7b164106596b50/hepcidin-ferroportin-interaction-controls-systemic-iron-homeostasis-figure-3.jpg)


Verification
Claims the paper makes
31 Valid · 2 Not valid · 28 Not checked · 21 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Because iron is exported against the force exerted by the transmembrane electric field, and there is no evidence of direct coupling of the transport to ATP hydrolysis, the export of iron is likely facilitated by the coupled “downhill” transport of another ion or small molecule [13].”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 4. Ferroportin Structure
What the sources say
- Disputedcites [13] Deshpande, 2018, Calcium is an essential cofactor for metal efflux by the ferroportin transporter family, Nat. Commun. sourceExperimental — accuracy not yet measured
The Results section reports that iron efflux does not depend on a transmembrane H+ gradient or Na+, and experiments do not support Fe2+/Ca2+ antiport. The paper instead identifies extracellular Ca2+ as a cofactor that activates ferroportin without being transported. These findings run contrary to the proposed downhill-coupled transport mechanism. (LLM, conf=0.84)
Checked by a reasoning model — may be wrong.
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 2 assumptions not shown here.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Efficient filtration of hepcidin in the glomerulus is facilitated by the relatively low fraction of hepcidin that is bound by plasma protein, estimated at about 40% [28].”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 6. Hepcidin Synthesis and Elimination
What the sources say
- Partly supportedcites [28] Diepeveen, L.E., Laarakkers, C.M., Peters, H.P.E., van Herwaarden, A.E., Groenewoud, H., IntHout, J., Wetzels, J.F., van Swelm, R.P.L., and Swinkels, D.W. (2019). Unraveling hepcidin plasma protein binding: Evidence from peritoneal equilibration testing. Pharmaceuticals, 12. sourceExperimental — accuracy not yet measured
The Abstract reports a hepcidin protein-bound fraction of 40% (±23%), and the Discussion says hepcidin is not predominantly bound and is rapidly excreted by the kidneys. The study used peritoneal dialysis in patients with end-stage renal disease; it does not establish that low protein binding facilitates efficient filtration in the glomerulus. (LLM, conf=0.86)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“A recent study [21] provide convincing evidence that Rnf217 is an important E3 ubiquitin ligase that triggers the degradation of ferroportin in response to hepcidin binding.”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 5. Ferroportin Interactions with Hepcidin
What the sources say
- Supportedcites [21] Jiang, L., Wang, J., Wang, K., Wang, H., Wu, Q., Yang, C., Yu, Y., Ni, P., Zhong, Y., and Song, Z. (2021). RNF217 regulates iron homeostasis through its E3 ubiquitin ligase activity by modulating ferroportin degradation. Blood. source
The Introduction states that hepcidin binds ferroportin and induces its internalization and degradation. The Results report that RNF217’s E3 ubiquitin ligase activity is required for ferroportin degradation and that hepcidin-mediated degradation is at least partially RNF217-dependent in mice. The paper also notes that RNF217 can promote degradation without added hepcidin in vitro, so the response to hepcidin is not its only observed mode of action. (LLM, conf=0.91)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Moreover, duodenal iron absorption increases several-fold after blood loss or exposure to hypoxia, or in response to iron deficiency.”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 2. Iron Compartments and Flows
What the sources say
- Partly supportedcites [3] Finch, 1994, Regulators of iron balance in humans, Blood sourceExperimental — accuracy not yet measured
The Store Regulator (p. 2) says absorption is high when iron stores are depleted, and The Erythroid-Regulator (p. 3) reports increased absorption after phlebotomy and in iron-deficiency anemia. The latter section links hypoxia to erythropoietin release, but does not report a several-fold rise in duodenal absorption after hypoxia exposure; it also does not establish a several-fold increase for each condition in the claim. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The model also revealed an important unexpected feature, the indication that the suspected hepcidin-binding site in the C-lobe, centered on the critically important C325 thiol cysteine, utilizes an iron atom to coordinate hepcidin binding [14].”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 5. Ferroportin Interactions with Hepcidin
What the sources say
- Partly supportedcites [14] Billesbolle, 2020, Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms, Nature sourceExperimental — accuracy not yet measured
The hepcidin-binding section (p. 6) supports the role of a C-domain metal site: iron greatly increases hepcidin affinity, and mutations at that site weaken binding. But the cited paper identifies the coordinating cysteine as C326, not C325; C325 is not the cysteine named in this claim. The structure directly shows cobalt, an iron mimetic, at the site. (LLM, conf=0.92)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
44 more claims · 19 with their cited sources checked
Create a free account to see all 82 claims and to verify the 10 references still open.
- It may state two separate claims as one. 31
- Probably not a substantial claim. 3
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 5. Ferroportin Interactions with Hepcidin
“the suspected hepcidin-binding site in the C-lobe, centered on the critically important C325 thiol cysteine”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 7. Evidence for Exclusivity of the Hepcidin-Ferroportin Ligand-Receptor Dyad
“the essential conserved amino acid at the ferroportin binding site for hepcidin, C326 (human numbering)”
Citations
Cites
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803 · cited 3×
“The flow of iron out of the cells is controlled by hepcidin through two known mechanisms: occlusion of the open-outward conformation of ferroportin by hepcidin [17], and hepcidin-induced endocytosis and degradation of ferroportin [4].”
BackgroundSelf-citationNemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650 · cited 2×
“Infection and inflammation induce hepcidin, predominantly through the effects of the cytokine interleukin-6 (IL-6) [52], and increased concentrations of hepcidin then inhibit ferroportin activity, leading to depletion of iron in plasma and extracellular fluid (hypoferremia).”
BackgroundSelf-citationHepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168 · cited 1×
“Hepcidin can also kill microbes on contact in vitro [59,60] but the concentrations required for this direct microbicidal activity exceeded its concentrations in extracellular fluid, even in inflamed models.”
BackgroundSelf-citationPositional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter
Donovan, A., Brownlie, A., Zhou, Y., Shepard, J., Pratt, S. J., Moynihan, J., Paw, B. H., Drejer, A., Barut, B., Zapata, A., et al. (2000) · Nature · doi:10.1038/35001596 · Cited by 1,667 · cited 1×
“During pregnancy, ferroportin is very highly expressed on the basal surface of syncytiotrophoblast in the placenta [7,50], where it plays an indispensable role in iron transfer to the fetus.”
BackgroundMcKie, A. T., Marciani, P., Rolfs, A., Brennan, K., Wehr, K., Barrow, D., Miret, S., Bomford, A., Peters, T. J., Farzaneh, F., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80425-6 · Cited by 1,422
Zimmermann, M. B., & Hurrell, R. F. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61235-5 · Cited by 1,405 · cited 1×
“Iron deficiency, iron deficiency anemia [65] and anemia of inflammation [66] are very common disorders affecting a large portion of the population.”
BackgroundDysmetabolic Hyperferritinemia: All Iron Overload Is Not Hemochromatosis
Makker, J., Hanif, A., Bajantri, B., & Chilimuri, S. (2015) · Case Reports in Gastroenterology · doi:10.1159/000373883 · Cited by 1,351
LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
Krause, A., Neitz, S., Mägert, H.-J., Schulz, A., Forssmann, W.-G., Schulz-Knappe, P., & Adermann, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01920-7 · Cited by 1,324 · cited 1×
“Hepcidin can also kill microbes on contact in vitro [59,60] but the concentrations required for this direct microbicidal activity exceeded its concentrations in extracellular fluid, even in inflamed models.”
BackgroundA Novel Mammalian Iron-regulated Protein Involved in Intracellular Iron Metabolism
Abboud, S., & Haile, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000713200 · Cited by 1,267
Cited by
The interaction between ferroptosis and inflammatory signaling pathways
Chen, Y., Fang, Z.-M., Yi, X., Wei, X., & Jiang, D.-S. (2023) · Cell Death & Disease · doi:10.1038/s41419-023-05716-0 · Cited by 567
“As the core node that modulates the distribution of iron in different organs, hepcidin is synthesized and secreted by hepatocytes and can hinder intracellular iron export by degrading ferroportin [132, 133].”
BackgroundIron imbalance in neurodegeneration
Levi, S., Ripamonti, M., Moro, A. S., & Cozzi, A. (2024) · Molecular Psychiatry · doi:10.1038/s41380-023-02399-z · Cited by 203
“As demonstrated for systemic iron absorption [6], several studies have reported the importance of hepcidin/ferroportin (Hep/Fpn) interactions [48] in regulating these exchanges between brain tissue cells [49].”
BackgroundIron deficiency and cardiovascular disease
Savarese, G., von Haehling, S., Butler, J., Cleland, J. G. F., Ponikowski, P., & Anker, S. D. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehac569 · Cited by 200
“Inflammation leads to an increased release of hepcidin, a liverexpressed type II acute phase protein and a major player in iron homeostasis.(3) Hepcidin regulates the degradation of ferroportin, a transmembrane protein which transports iron absorbed after dietary intake from the inside of the mucosal cells in the smal…”
BackgroundIron and the pathophysiology of diabetes
Harrison, A. V., Lorenzo, F. R., & McClain, D. A. (2023) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022522-102832 · Cited by 161
“While necessary for metabolism, iron is also a potent oxidant, and complex systems to regulate its uptake, storage, and bioavailability also evolved (3,4) (Figure 1).”
BackgroundIron Metabolism in Cardiovascular Disease: Physiology, Mechanisms, and Therapeutic Targets
Sawicki, K. T., Jesus, A. D., & Ardehali, H. (2023) · Circulation Research · doi:10.1161/circresaha.122.321667 · Cited by 179
Ferroptosis in sepsis: The mechanism, the role and the therapeutic potential
Lei, X. L., Zhao, G. Y., Guo, R., & Cui, N. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.956361 · Cited by 170
“The hepcidinferroportin-1 (Fpn1) axis, which reduces plasma iron concentrations in response to infection and inflammation, limits the availability of iron to invading microorganisms (17).”
BackgroundMechanisms and regulations of ferroptosis
Zhang, X.-D., Liu, Z., Wang, M.-S., Guo, Y.-X., Wang, X., Luo, K., Huang, S., & Li, R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1269451 · Cited by 173
“A recent study revealed that hepcidin binding to FPN is coupled to iron binding, and the af fi nity of hepcidin increases 80 times in the presence of iron (99).”
BackgroundInfluentialBiology of Anemia: A Public Health Perspective
Brittenham, G. M., Moir-Meyer, G., Abuga, K. M., Datta-Mitra, A., Cerami, C., Green, R., Pasricha, S., & Atkinson, S. H. (2023) · Journal of Nutrition · doi:10.1016/j.tjnut.2023.07.018 · Cited by 155
New Insights into Iron Deficiency Anemia in Children: A Practical Review
Moscheo, C., Licciardello, M., Samperi, P., Spina, M. L., Cataldo, A. D., & Russo, G. M. (2022) · Metabolites · doi:10.3390/metabo12040289 · Cited by 146
“Hepcidin, by binding to FPN and inducing internalization and degradation, inhibits the release of iron from cells [22,26,27], negatively impacting the absorption of iron from the duodenum and its release from the macrophages of the liver and spleen [28,29] (Figure 2).”
BackgroundIron-Induced Oxidative Stress in Human Diseases
Kawabata, T. (2022) · Cells · doi:10.3390/cells11142152 · Cited by 101
“Excess iron is brought to FPN1 and excreted into the extracellular space [51,52].”
BackgroundShen, Y., Nie, C., Wei, Y., Zheng, Z. J., Xu, Z., & Xiang, P. (2022) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2022.214676 · Cited by 88
Iron metabolism and iron deficiency anemia in women
Cappellini, M. D., Santini, V., Braxs, C., & Shander, A. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.08.014 · Cited by 140
Zhang, S., Xu, J., Si, H., Wu, Y., Zhou, S., & Shen, B. (2022) · Antioxidants · doi:10.3390/antiox11091668 · Cited by 94
“Hepcidin, a key regulator of systemic iron homeostasis, is a small circulating peptide produced mainly by hepatocytes and can bind FPN on enterocytes, macrophages, and other cells to trigger FPN degradation and block iron efflux [16].”
BackgroundBao, X., Luo, X., Bai, X., Lv, Y., Weng, X., Zhang, S., Leng, Y., Huang, J., Dai, X., Wang, Y., et al. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.03.006 · Cited by 89
Iron, Oxidative Stress, and Metabolic Dysfunction—Associated Steatotic Liver Disease
Gensluckner, S., Wernly, B., Datz, C., & Aigner, E. S. (2024) · Antioxidants · doi:10.3390/antiox13020208 · Cited by 96
The crosstalk between mitochondrial quality control and metal-dependent cell death
Zhou, Q.-Y., Ren, C., Li, J., Wang, L., Duan, Y., Yao, R.-Q., Tian, Y., & Yao, Y.-M. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06691-w · Cited by 95
Da, Z., Yang, K., Guo, H., Zeng, J., Wang, S., Xu, H., Ge, A., Zeng, L., Chen, S., & Ge, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114312 · Cited by 80
Emerging Roles of the Iron Chelators in Inflammation
Paola, A. D., Tortora, C., Argenziano, M., Marrapodi, M. M., & Rossi, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147977 · Cited by 83
“At the cellular level, the iron regulatory proteins (IRPs), IRP1 and IRP2 are the main protagonists, participating in the modulation of DMT1, TfR-1, FPN1 and ferritin levels [15].”
BackgroundKey players in the regulation of iron homeostasis at the host-pathogen interface
Ullah, I., & Lang, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1279826 · Cited by 87
“Induction of hepcidin also results in the development of hypoferremia and eventually, anemia which are well-known mechanisms occurring upon in fl ammation and infection (89).”
BackgroundLiao, J., Wei, M., Wang, J., Zeng, J., Liu, D., Du, Q., Ge, J., & Mei, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115465 · Cited by 80
Xue, M., Tian, Y., Sui, Y., Zhao, H. J., Gao, H., Liang, H., Qiu, X., Sun, Z., Zhang, Y., & Qin, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113402 · Cited by 68
Iron and iron-related proteins in COVID-19
Suriawinata, E., & Mehta, K. J. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-022-00851-y · Cited by 72
“Hepatocyte iron stores represent the second largest iron compartment which contains about 1 g of iron [51].”
BackgroundInfluentialWang, M., Tang, G., Zhou, C., Guo, H., Hu, Z., Hu, Q., & Li, G. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110387 · Cited by 66
SLC40A1 in iron metabolism, ferroptosis, and disease: A review
Zhang, Y., Zou, L., Li, X., Guo, L., Hu, B., Ye, H., & Liu, Y. (2024) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1644 · Cited by 90
Hepcidin in hepatocellular carcinoma
Joachim, J. H., & Mehta, K. J. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01753-2 · Cited by 60
“Thus, hepcidin regulates systemic iron levels [9, 10].”
BackgroundInfluentialEffects of CB2 Receptor Modulation on Macrophage Polarization in Pediatric Celiac Disease
Tortora, C., Paola, A. D., Argenziano, M., Creoli, M., Marrapodi, M. M., Cenni, S., Tolone, C., Rossi, F., & Strisciuglio, C. (2022) · Biomedicines · doi:10.3390/biomedicines10040874 · Cited by 47
“Hepcidin, the main factor responsible for iron metabolism modulation, acts by binding to the iron transporter ferroportin 1 (FPN-1) causing its internalization and degradation [26].”
BackgroundInfluentialSze, S. C. W., Zhang, L., Zhang, S., Lin, K., Ng, T. B., Ng, M. L., Lee, C., Lam, J. K. W., Zhang, Z., & Yung, K. K. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012689 · Cited by 53
“Hepcidin synthesis is induced by inflammatory interleukin-6 and activin B [10,11].”
BackgroundMechanism of Iron Ion Homeostasis in Intestinal Immunity and Gut Microbiota Remodeling
Bao, H., Wang, Y., Xiong, H., Xia, Y., Cui, Z., & Liu, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020727 · Cited by 49
“…cell types that regulate iron circulation in the body (Figure 1): intestinal cells in the duodenum obtain iron from food; red blood cell precursors in the bone marrow add iron to the hemoglobin [11]; macrophages in the liver, spleen, and bone marrow reclaim iron; and liver cells store iron [12].”
Zhang, L., Dai, X., Wang, L., Cai, J., Shen, J., Shen, Y., Li, X., & Zhao, Y. M. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.961892 · Cited by 55
Sun, B., Tan, B., Zhang, P., Zhu, L., Wei, H., Huang, T., Li, C. L., & Yang, W. (2024) · Food & Function · doi:10.1039/d3fo04644c · Cited by 55
Iron deficiency and supplementation in heart failure
Lakhal‐Littleton, S., & Cleland, J. G. F. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-00988-1 · Cited by 54
Zhang, H., Shi, H., Li, X., Zhou, S., Song, X., Ma, N., Meng, M., Chang, G., & Shen, X. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103557 · Cited by 48
“Hepcidin binds to FPN and mediates ubiquitination of FPN, resulting in FPN endocytosis and eventual degradation [51].”
Lactoferrin: from the structure to the functional orchestration of iron homeostasis
Ianiro, G., Rosa, L., di Patti, M. C. B., Valenti, P., Musci, G., & Cutone, A. (2022) · BioMetals · doi:10.1007/s10534-022-00453-x · Cited by 48
“Different parameters influence hepcidin expression, including systemic iron status, erythropoiesis iron requirement, hypoxia and inflammation (Nemeth and Ganz 2021).”
BackgroundInfluentialIron-tracking strategies: Chaperones capture iron in the cytosolic labile iron pool
Philpott, C. C., Protchenko, O. V., Wang, Y., Novoa‐Aponte, L., León-Torres, A., Grounds, S., & Tietgens, A. J. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1127690 · Cited by 47
“At the systemic level, intestinal iron absorption is regulated by hepcidin, a 25-amino acid-peptide hormone secreted by the liver and other tissues that binds ferroportin on basolateral membranes of intestinal epithelial cells and blocks its activity (Drakesmith et al., 2015; Nemeth and Ganz, 2021).”
BackgroundMyeloid cell iron uptake pathways and paramagnetic rim formation in multiple sclerosis
Hofmann, A., Krajnc, N., Dal‐Bianco, A., Riedl, C. J., Zrzavy, T., Lerma-Martin, C., Kasprian, G. J., Weber, C. E., Pezzini, F., Leutmezer, F., et al. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02627-4 · Cited by 46
“Hemoglobin contains by far the largest pool of iron in the human body [42].”
BackgroundMaternal, fetal and placental regulation of placental iron trafficking
O'Brien, K. O. (2021) · Placenta · doi:10.1016/j.placenta.2021.12.018 · Cited by 49
Exosome Cargos as Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
Zeng, Y., Hu, S., Luo, Y., & He, K. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15092365 · Cited by 38
Marques, O., Horvat, N. K., Zechner, L., Colucci, S., Sparla, R., Zimmermann, S., Neufeldt, C. J., Altamura, S., Qiu, R., Müdder, K., et al. (2024) · Blood · doi:10.1182/blood.2023023417 · Cited by 50
Zhang, C., Lu, S., Deng, K. Y., Qian, W., Liu, Y., Li, Y., Jin, S., Suo, R., Xu, H., & Wu, B. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202301462 · Cited by 42
Liver sinusoidal endothelial cells induce BMP6 expression in response to non–transferrin-bound iron
Charlebois, E., Fillebeen, C., Presley, J., Cagnone, G., Lisi, V., Lavallée, V., Joyal, J., & Pantopoulos, K. (2022) · Blood · doi:10.1182/blood.2022016987 · Cited by 40
Identification of three mechanistic pathways for iron-deficient heart failure
Packer, M., Anker, S. D., Butler, J., Cleland, J. G. F., Kalra, P. R., Mentz, R. J., & Ponikowski, P. P. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae284 · Cited by 43
“11 When erythropoiesis is stimulated, erythroblasts release erythroferrone, which (by suppressing the synthesis of hepcidin by the liver) allows the enhanced entry of iron into the bloodstream to support red blood cell production.”
BackgroundDaily oral iron supplementation during pregnancy
Finkelstein, J. L., Cuthbert, A., Weeks, J., Venkatramanan, S., Larvie, D. Y., De‐Regil, L. M., & Garcia‐Casal, M. N. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004736.pub6 · Cited by 100
Aptamer-based targeted drug delivery and disease therapy in preclinical and clinical applications
Yang, W., Ran, C., Lian, X., Wang, Z., Du, Z., Bing, T., Zhang, Y., & Tan, W. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115680 · Cited by 42
Structures and coordination chemistry of transporters involved in manganese and iron homeostasis
Ray, S., & Gaudet, R. (2023) · Biochemical Society Transactions · doi:10.1042/bst20210699 · Cited by 32
Regulation of erythropoiesis: emerging concepts and therapeutic implications
Tang, P., & Wang, H. (2023) · Hematology · doi:10.1080/16078454.2023.2250645 · Cited by 51
“Ferritin is then targeted for lysosomal and proteasomal degradation through ubiquitination, which is facilitated by Rnf217, an important E3 ubiquitin ligase [26,34].”
BackgroundInfluentialZhang, W., Wang, J., Liu, Z., Zhang, L., Jing, J., Lin, H., & Gao, A. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.10.273 · Cited by 34
Homocysteine induces ferroptosis in endothelial cells through the systemXc−/GPX4 signaling pathway
Shi, J., Chen, D., Wang, Z., Li, S., & Zhang, S. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03342-4 · Cited by 32
“The regulation of intracellular iron homeostasis is mainly regulated by transferrin receptors, iron pump proteins, and intracellular ferritin on the cell membrane surface [13].”
BackgroundSiderophores and beyond: A comprehensive review of iron acquisition in Klebsiella pneumoniae
Lan, P., Lu, Y., Fu, Y., Yu, Y., & Zhou, J. (2025) · Virulence · doi:10.1080/21505594.2025.2550621 · Cited by 37
“Hepcidin regulates iron absorption from the diet and iron recycling from macrophages by targeting the iron exporter ferroportin (SLC40A1) for degradation [3].”
Iron dysregulation in COVID‐19 and reciprocal evolution of SARS‐CoV‐2: Natura nihil frustra facit
Gupta, Y., Maciorowski, D., Medernach, B., Becker, D. P., Durvasula, R., Libertin, C. R., & Kempaiah, P. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30207 · Cited by 35
“described the target site of Hepcidin as ferroportin.(25) Ferroportin is an iron exporter on the surface of absorptive intestinal enterocytes, macrophages, hepatocytes, and placental cells, responsible for releasing iron into plasma.”
BackgroundSevere anaemia, iron deficiency, and susceptibility to invasive bacterial infections
Abuga, K. M., Nairz, M., MacLennan, C. A., & Atkinson, S. H. (2023) · Wellcome Open Research · doi:10.12688/wellcomeopenres.18829.1 · Cited by 37
Selected Trace Elements and Their Impact on Redox Homeostasis in Eye Health
Wróblewska, J., Nuszkiewicz, J., Wróblewski, M., Wróblewska, W., & Woźniak, A. (2024) · Biomolecules · doi:10.3390/biom14111356 · Cited by 37
“Ferritin, on the other hand, stores excess iron, preventing it from participating in harmful redox reactions and offering protection against iron-induced damage in retinal cells [33].”
The complex interplay between ferroptosis and atherosclerosis
Zhang, M., Li, J., & Hu, W. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117183 · Cited by 33
Tian, S., Wang, B., Ding, Y., Zhang, Y. L., Yu, P., Chang, Y.-Z., & Gao, G. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117419 · Cited by 32
Interaction between macrophages and ferroptosis: Metabolism, function, and diseases
Jiang, Q., Wan, R., Jiang, J., Li, T., Li, Y., Yu, S., Zhao, B., & Li, Y. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003189 · Cited by 37
“…reduce free radicals and lipid peroxides Inhibit [10] FSP1/DHODH/CoQ10 Ubiquinol (CoQ10H 2 ) reduces free radicals and lipid peroxides Inhibit [19,20] GCH/BH4 BH4 reduces free radicals and lipid peroxides directly or via synthetic ubiquinol Inhibit [21] Iron metabolism Fe 2+ Generate ROS through…”
InfluentialHolland, C., Dravecz, N., Owens, L., Benedetto, A., Dias, I. H. K., Gow, A. J., & Broughton, S. J. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102461 · Cited by 34
Association of iron-related biomarkers with severity and mortality in COVID-19 patients
Yadav, D., Kumar, P. K., Tomo, S., Sankanagoudar, S., Charan, J., Purohit, A. H. L., Nag, V., Bhatia, P. K., Singh, K., Dutt, N., et al. (2022) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2022.127075 · Cited by 28
“Similarly, when the levels of hepcidin increase, the ferroportin gets internalised and iron gets accumulated in the tissues and cells [52].”
Kobayashi, H., Yoshimoto, C., Matsubara, S., Shigetomi, H., & Imanaka, S. (2023) · Diagnostics · doi:10.3390/diagnostics13111926 · Cited by 38
“Ferroportin exports iron from granulosa cells, and hepcidin blocks cellular iron release through ferroportin [83].”
BackgroundInfluentialVera‐Aviles, M., Kabir, S. N., Shah, A., Polzella, P., Lim, D. Y., Buckley, P., Ball, C., Swinkels, D. W., Matlung, H. L., Blans, C., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae359 · Cited by 29
“28,29,40 That iron taken up into the myocardium remains labile 42 days later, is consistent with the fact that the myocardium is not a specialized organ of iron handling, and has relatively limited capacity for iron storage and turnover.”
BackgroundThe role of ferroptosis in virus infections
Wang, J., Zhu, J., Ren, S., Zhang, Z., Niu, K., Li, H., Wu, W., & Chen, P. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1279655 · Cited by 36
“Hepcidin, a key protein for iron homeostasis, binds to ferritin and leads to its internalization and degradation (Ginzburg, 2019; Nemeth and Ganz, 2021).”
BackgroundInflammation in a ferroptotic environment
Wickert, A., Schwantes, A., Fuhrmann, D. C., & Brüne, B. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1474285 · Cited by 31
“Under in fl ammatory conditions, iron uptake increases in conjunction with an attenuated release, due to a lower FPN surface expression as a result of hepcidin (HAMP) evoked degradation of the iron exporter (Nemeth and Ganz, 2021).”
BackgroundHypoferremia of inflammation: Innate host defense against infections
Ganz, T., & Nemeth, E. (2023) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2023.102777 · Cited by 32
Self-citationWang, L., Liu, Y., Li, S., Zha, Z., Chen, Y., Wang, Q., Zhou, S., Huang, X., & Xu, M. (2023) · Aging · doi:10.18632/aging.205138 · Cited by 27
“SLC40A1, also known as FPN1, encodes the iron transport protein that exports iron out of cells, while TRF allows iron to be taken up by cells by binding to transferrin receptors (TFR) [29, 30].”
Structures of ferroportin in complex with its specific inhibitor vamifeport
Lehmann, E. F., Liziczai, M., Drożdżyk, K., Altermatt, P., Langini, C., Manolova, V., Sundström, H., Dürrenberger, F., Dutzler, R., & Manatschal, C. (2023) · eLife · doi:10.7554/elife.83053 · Cited by 29
Unlocking iron: nutritional origins, metabolic pathways, and systemic significance
Malik, Z. I., Ghafoor, M. U., Shah, S. H. B. U., Abid, J., Farooq, U., & Ahmad, A. M. R. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1637316 · Cited by 39
Xu, M., Li, Y., Meng, D., Zhang, D., Wang, B., Xie, J., & Wang, J. (2022) · Biomolecules · doi:10.3390/biom12020266 · Cited by 29
“6-OHDA Decreases Hepcidin Release in BV2 Cells Given that the hepcidin–FPN1 axis regulates iron metabolism via the feedback effects of hepcidin, the hepcidin–FPN1 axis controls and regulates the body’s iron homeostasis [22,28,29].”
BackgroundInfluentialPacker, M., Anker, S. D., Butler, J., Cleland, J. G. F., Kalra, P. R., Mentz, R. J., Ponikowski, P. P., & Talha, K. M. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3237 · Cited by 32
Resveratrol ameliorates iron overload induced liver fibrosis in mice by regulating iron homeostasis
Wang, H., Jiang, C., Yang, Y., Li, J., Wang, Y., Wang, C., & Gao, Y. (2022) · PeerJ · doi:10.7717/peerj.13592 · Cited by 31
“…absorption and tissue distribution are mainly controlled by the interaction of hepatic hepcidin with FPN. Excess iron allows hepatocytes to produce more hepcidin, which regulates iron homeostasis by binding FPN-1 extracellularly to internalize and degrade FPN-1 in lysosomes ( Nemeth & Ganz, 2021 ).”
Mathew, M., Sivaprakasam, S., Phy, J. L., Bhutia, Y. D., & Ganapathy, V. (2023) · Bioscience Reports · doi:10.1042/bsr20212234 · Cited by 27
Regulation of the p53‑mediated ferroptosis signaling pathway in cerebral ischemia stroke (Review)
Xu, S., Li, X., & Wang, Y. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.11812 · Cited by 25
“Iron oxidases ceruloplasmin (CP), hephaestin (HEPH) and HEPH like 1 (bacteriophage like 1) can all regulate iron balance through SLC40A1‐dependent iron output (45,46).”
BackgroundDawi, J., Affa, S., Gonzalez, E., Misakyan, Y., Nikoghosyan, D., Hajjar, K., Kades, S., Fardeheb, S., Mirzoyan, H., & Venketaraman, V. (2024) · Biomedicines · doi:10.3390/biomedicines12030558 · Cited by 30
“Genetic hepcidin deficiency can lead to severe forms of hemochromatosis and, consequently, abnormally high iron levels in the heart [57].”
BackgroundNatural Tannin and Upconversion Photons Co‐Potentiate Fe Fenton Anticancer Therapy
Qu, J., Li, C., Xu, J., et al. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202503641 · Cited by 23
Zhang, V., Jenkitkasemwong, S., Liu, Q., Ganz, T., Nemeth, E., Knutson, M. D., & Kim, A. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022007867 · Cited by 27
“Hepcidin-mediated hypoferremia during infections is an important form of nutritional immunity.(1,8) Neutrophil gelatinase–associated lipocalin prevents bacterial iron uptake by sequestering siderophores, bacterial compounds that bind to iron for active uptake by the microbe.”
BackgroundSelf-citationThe Role of Iron and Cobalt in Gynecological Diseases
Ćwiertnia, A., Kozłowski, M., & Cymbaluk‐Płoska, A. (2022) · Cells · doi:10.3390/cells12010117 · Cited by 27
Iron metabolism and chronic inflammation in IgA nephropathy
Tian, Z.-Y., Li, Z., Chu, L., Liu, Y., He, J., Yu, X., Li, A., & Zhang, H. (2023) · Renal Failure · doi:10.1080/0886022x.2023.2195012 · Cited by 26
“the supply of iron to invading microorganisms [29].”
BackgroundIron-dependent mechanisms in Acinetobacter baumannii : pathogenicity and resistance
Zhang, R., Li, D. H., Fang, H. Y., Xie, Q., Tang, H., & Chen, L. (2025) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaf039 · Cited by 29
The role of microglia in neurodegenerative diseases: from the perspective of ferroptosis
Liu, Y., Jia, G.-R., Zhang, S.-H., Guo, Y., Ma, X., Xu, H., & Xie, J. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01560-4 · Cited by 33
“It can occlude the open-outward conformation of ferroportin and induce endocytosis and degradation of ferroportin, resulting in the removal of FPN1 at the cell membrane and a decrease of iron output from the cell [42, 43].”
Iron deficiency and overload in men and woman of reproductive age, and pregnant women
Li, X., Duan, X., Tan, D., Zhang, B., Xu, A., Qiu, N., & Chen, Z. (2023) · Reproductive Toxicology · doi:10.1016/j.reprotox.2023.108381 · Cited by 45
Morel, L. M., & Scindia, Y. M. (2024) · Clinical Immunology · doi:10.1016/j.clim.2024.110181 · Cited by 22
Ferroptosis: A New Direction in the Treatment of Intervertebral Disc Degeneration
Mei, Y., Wang, L., Chen, T., Song, C., Cheng, K., Cai, W., Zhou, D., Gao, S., Jiang, F., Liu, S., et al. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01468-6 · Cited by 25
“Hepatic secretion of ferroportin (Hepcidin, Hepc) can regulate iron levels through the intestine and macrophages, as well as by inhibiting FPN [33].”
Mechanism and regulation of iron absorption throughout the life cycle
Qiu, L., Frazer, D. M., Hu, M., Song, R., Liu, X., Qin, X., Ma, J., Zhou, J., Tan, Z., Ren, F., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.01.002 · Cited by 38
Accumulation of Intracellular Ferrous Iron in Inflammatory-Activated Macrophages
Ma, H., Shu, Q., Li, D., Wang, T., Li, L., Song, X., Lou, K., & Xu, H. (2022) · Biological Trace Element Research · doi:10.1007/s12011-022-03362-9 · Cited by 26
“In human body, systemic Fe metabolism is closely regulated by the liver-derived hormone hepcidin, which induces the internalization and degradation of Fe(II) exporter Slc40a1, leading to Fe sequestration in cells [31].”
BackgroundYang, M., Yu, H., Xu, K., Xie, J., Zheng, H., Feng, R., Wang, J., & Xu, P. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1047640 · Cited by 27
“This leads to iron accumulation in cells, and the resulting serum iron deficiency causes changes in serum iron homeostasis indicators (51, 52).”
BackgroundIron chelators as a therapeutic option for Alzheimer’s disease—A mini-review
Schreiner, O. D., & Schreiner, T. G. (2023) · Frontiers in Aging · doi:10.3389/fragi.2023.1234958 · Cited by 28
“, 2015) located at the apical side of the intestinal cell or by ferroportin (Nemeth and Ganz, 2021), located at the basal side of the enteric cell, is mandatory to develop therapeutic means which could enhance or limit iron absorption according to individual needs.”
BackgroundPacker, M. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3238 · Cited by 21
Jiang, Y., Zhang, L., Lin, Y., Zhu, X., Wang, T., Zhu, Z., Chen, Y., & Tang, D. (2025) · Molecules and Cells · doi:10.1016/j.mocell.2025.100264 · Cited by 26
Ferroptosis in ischemic stroke: mechanisms, pathological implications, and therapeutic strategies
Long, Z., Zhu, Y., Zhao, H., Liao, S., & Liu, C. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1623485 · Cited by 34
“This export process is modulated by hepcidin, a liver-derived hormone that regulates ferroportin activity in response to systemic iron levels and inflammation (Nemeth and Ganz, 2021; Wang and Babitt, 2019).”
Mechanism of Ca2+ transport by ferroportin
Shen, J., Wilbon, A. S., Zhou, M., & Pan, Y. (2023) · eLife · doi:10.7554/elife.82947 · Cited by 23
“Ferroportin (Fpn), encoded by SLC40A1 gene, is the only known Fe2+ exporter in human (Nemeth and Ganz 2021; Abboud and Haile 2000; Donovan et al. 2000; McKie et al. 2000).”
BackgroundInfluentialLewis, J. P., & Gui, Q. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.04733-22 · Cited by 19
To Boost or to Reset: The Role of Lactoferrin in Energy Metabolism
Ianiro, G., Niro, A., Rosa, L., Valenti, P., Musci, G., & Cutone, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115925 · Cited by 23
“Reconstituted dried cow’s milk, commonly used as an alternative source, also contains the glycoprotein but in lower concentrations compared with human milk [142].”
BackgroundThe Pan-liver Network Theory: From Traditional Chinese Medicine to Western Medicine
Zhang, Y., & Fang, X.-M. (2023) · The Chinese Journal of Physiology · doi:10.4103/cjop.cjop-d-22-00131 · Cited by 30
Liu, D., Hu, Z., Lu, J., & Yi, C. (2024) · Antioxidants · doi:10.3390/antiox13070791 · Cited by 24
“Elevated iron levels enhance hepcidin binding to FPN, reducing iron release, while decreased hepcidin levels reverse this effect [48].”
BackgroundKaramantziani, T., Pouliakis, A., Xanthos, T. T., Ekmektzoglou, K. A., Paliatsiou, S., Sokou, R., & Iacovidou, N. M. (2024) · Children · doi:10.3390/children11020231 · Cited by 24
Alwahsh, S. M., Xu, M., Itmezeh, A., Kim, M., & Ramadori, G. P. (2025) · Histochemistry and Cell Biology · doi:10.1007/s00418-025-02402-4 · Cited by 25
“The regulation of FPN and hemojuve-lin (HJV) is influenced by pretranslational gene expression (Nemeth and Ganz 2021; Xia et al. 2008).”
Wang, Z., Dang, Y., Li, Y., Zhang, Y., Zhou, S., Zhang, Z., & Wang, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1691705 · Cited by 36
“Conversely, low hepcidin levels increase iron export from hepatocytes and macrophages, increasing plasma iron and transferrin saturation (159).”
Mitochondrial Iron Handling and Lipid Peroxidation as Drivers of Ferroptosis
Bucarey, J. L., Casas, M., & Espinosa, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052232 · Cited by 30
“The liver-derived peptide hormone hepcidin is a negative regulator of iron homeostasis, binding to the iron exporter ferroportin, leading to its internalization and degradation [15].”
Relevance of biometals during neuronal differentiation and myelination: in vitro and in vivo studies
Chin-Chan, M., Montes, S., Blanco-Álvarez, V. M., Aguirre‐Alarcón, H., Rodríguez, I. H., & Bautista, E. (2022) · BioMetals · doi:10.1007/s10534-022-00380-x · Cited by 22
Iron accumulation and its impact on osteoporotic fractures in postmenopausal women
Cai, H., Zhang, H., He, W., & Zhang, H. (2023) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2200519 · Cited by 19
“Hepcidin itself is the main regu‐ lator of iron homeostasis (Nemeth and Ganz, 2021).”
BackgroundMoradi, S., Foshati, S., Poorbaferani, F., Talebi, S., Bagheri, R., Amirian, P., Parvizi, F., Nordvall, M., Wong, A., & Zobeiri, M. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.08.019 · Cited by 31
Nutritional Modulation of Hepcidin in the Treatment of Various Anemic States
D’Andrea, P., Giampieri, F., & Battino, M. A. (2023) · Nutrients · doi:10.3390/nu15245081 · Cited by 20
“In the second case, hepcidin triggers endocytosis and ubiquitination in the lysine residues of the cytosolic loop by Rnf217 ligase E3, resulting in channel degradation [2,8].”
InfluentialUguen, K., Ka, C., Collod‐Béroud, G., Tertre, M. L., Guellec, J., Férec, C., Béroud, C., Callebaut, I., & Gac, G. L. (2023) · Human Mutation · doi:10.1155/2023/5162256 · Cited by 20
Metadata
- Authors
- Nemeth, E., & Ganz, T.
- Affiliations
- University of California, Los Angeles (US)
- Corresponding author
- Ganz, Tomas
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-06-17
- Volume
- 22
- Issue
- 12
- Pages
- 6493
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8235187
- OpenAlex
- W3172506357
- Semantic Scholar
- 8da9eb7ee1579f5db94cd40eca5fde949bb5967c
- Cited by
- 540
- References
- 69
- Citations by year
- 2026: 101 · 2025: 143 · 2024: 107 · 2023: 110 · 2022: 71 · 2021: 7
- FWCI
- 12.91
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD096863)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- hepcidin, ferroportin, SLC40A1, iron homeostasis, iron export, hypoferremia, compensatory erythropoiesis, iron deficiency, hereditary hemochromatosis, inflammation, infection, iron overload, iron recycling, macrophages, hepatocytes
- MeSH terms
- Ferroportin, Animals, Biological Transport, Disease Susceptibility, Homeostasis, Humans, Iron, Ligands, Protein Binding, Tissue Distribution, Signal Transduction, Autocrine Communication, Paracrine Communication, Cation Transport Proteins, Metabolic Networks and Pathways, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.